The reason for the decline of Cape's biological performance may be influenced by the centralized collection of nucleic acid detection. On May 10 this year, Cape Bio disclosed the Announcement on Selection and Procurement of Products Related to Nucleic Acid Detection, and Chaozhou Cape Biochemistry Co., Ltd. "novel coronavirus 20 19-nCoV Nucleic Acid Detection Kit (fluorescent PCR method)" and other products planned to select the commonly used nucleic acid reagents and kits in the 1 procurement list. Judging from the selected price, a set of COVID-19 nucleic acid testing price.
Guangdong Kaipu Biotechnology Co., Ltd. is a leading enterprise of human papillomavirus -DNA detection reagent in China. Cape always focuses on the independent research and development of molecular diagnostic technology, actively expands the application field of nucleic acid molecular diagnostic technology, and constantly promotes the transformation and upgrading of nucleic acid molecular diagnostic application technology.